Portal de Periódicos da CAPES

Effect of perioperative aspirin use on hemorrhagic complications in elective craniotomy for brain tumors: results of a single-center, retrospective cohort study

2019; American Association of Neurological Surgeons; Volume: 132; Issue: 5 Linguagem: Inglês

10.3171/2018.12.jns182483

1933-0693

Şahin Hanalıoğlu, Balkan Şahin, Ömer Selçuk Şahin, Abdulbaki Kozan, Melih Üçer, Ulaş Cıkla, Steven L. Goodman, Mustafa K. Başkaya,

Inflammatory mediators and NSAID effects

In daily practice, neurosurgeons face increasing numbers of patients using aspirin (acetylsalicylic acid, ASA). While many of these patients discontinue ASA 7-10 days prior to elective intracranial surgery, there are limited data to support whether or not perioperative ASA use heightens the risk of hemorrhagic complications. In this study the authors retrospectively evaluated the safety of perioperative ASA use in patients undergoing craniotomy for brain tumors in the largest elective cranial surgery cohort reported to date.